Digital support for paediatric obesity care
Obesity care doesn't stop between visits
Evira is a digital support for combined lifestyle treatment for childhood obesity – with a documented twofold effect after one year and close treatment contact between visits.
Evira has been used in clinical practice since 2018
Så här används Evira idag
- treatment centres
48
treatment centres
- countries
6
countries
- clinics in the UK
16
clinics in the UK
- Swedish regions
6
Swedish regions
Läs om hur vårdgivare använder Evira i klinisk praktik
"We are glad that we started using Evira at our clinic. It brings life to the treatment! To be able to give continuous support and notice both negative and positive trends in time. Finally, we can work proactively with this patient group!"
Clinical effect
Twice as good as conventional treatment
Evira improves care by strengthening the alliance with the family, offering rapid feedback, and doubling the results after one year, with a lasting effect after three years.
−0.30 BMI SDS
Better weight development after one year than standard treatment (−0.15)
Pragmatic clinical study with comparison to the quality register BORIS, International Journal of Obesity 2022.
See the study3 years
Effect maintained for up to three years, with significantly fewer dropouts
Follow-up of the same cohort, 428 patients, International Journal of Obesity 2025.
See the follow-up−0,20 BMI z-score
Comparable results in two healthcare systems after 26 weeks
Peer-reviewed international study, Abu Dhabi and Stockholm, BMC Pediatrics 2026.
Read the study
Workflow and workload
How the Evira method works in clinical practice
See how Evira works – in 40 seconds
From monitoring at home to the right support between appointments.
Combined lifestyle treatment together with Evira enables long-term follow-up and close contact between visits.
- 01
Numberless measurement at home
The family measures regularly with the measuring plate – a connected scale that shows no numbers.
- 02
Trend and deviation analysis
The healthcare provider sees which patients are deviating from their goal and can prioritise the right families.
- 03
The right support at the right time
The team acts proactively between visits when a trend breaks, instead of discovering it retrospectively.
The cycle is repeated between visits. Visits every 3–6 months.
The entire treatment flow step by stepClinical everyday life with Evira
Responsibility
The healthcare provider is responsible for assessment, treatment, and documentation. Evira is a support in that treatment, not an independent healthcare provider.
Working method
The team works in the web interface between appointments: monitoring trends, answering questions, and prioritising families who deviate from their goal.
Resources
Follow-up is consolidated rather than appointment by appointment, meaning more families can receive close contact within existing staffing levels.
Evidence
Evira supports the treatment that is already recommended
Combined lifestyle treatment (KLB) is the basis of all childhood obesity treatment and aims for healthy weight development. According to the care programme, KLB should be individualised and age-adapted, structured, long-term, and evidence-based, and can be carried out through physical visits or remotely, individually or in groups.
The care programme describes that the intensity of the treatment is crucial for the outcome and that the treatment needs to correspond to at least 26 hours per year. Maintaining regular treatment contact is also described as a challenge.
The care programme describes digital treatment support as developed to complement physical visits, with a greater ability to maintain close treatment contact with the family. To use them, a clear agreement is required to manage costs, personal data, care responsibility, and patient data.
National care programme for the treatment of obesity in children and adolescents (2023-05-15)
Documented effect according to the care programme
The care programme compiles documented effects for treatment interventions with a minimum treatment period of 12 months, measured by change in BMI SDS. Evira is included in the compilation.
−0,30
BMI SDS
Evira + combined lifestyle treatment
4–18 years · 107 children · at least 12 months of treatment
Combined lifestyle intervention
−0,13 till −0,15
Intensiv kombinerad levnadsvanebehandling
−0,17 till −0,30
Evira + combined lifestyle treatment
−0,30
The results are from different studies with different populations and study designs and should not be interpreted as a direct comparative study between treatment methods.
Usage and acceptance
Evira is used here today
Evira is used in paediatric clinics and child and adolescent medical clinics in Sweden, as well as in specialist clinics in the UK that treat complications from excess weight (CEW). Evira is also used in clinical research in several European countries.
Sweden
United Kingdom – CEW clinics
The British clinics are CEW (Complications from Excess Weight) clinics – NHS specialist clinics for children and young people with obesity and its associated diseases. Read more at NHS England.
Bristol
Voices from families and healthcare providers
“For the family, it hasn’t been about staring blindly at weight in kilos, but rather understanding trends, learning about portions, and gaining motivation through positive feedback from responsible healthcare providers.”
Safety and responsibility
Safety and patient data
Evira is a CE-marked medical device in Class I according to MDR. Patient data is processed within the EU, with data processing agreements and information security work according to healthcare requirements.
Security and patient data in detailNext step
Implementation at the clinic
Implementation takes place incrementally, with clear division of responsibility and training before the first families start.
- 01
Review
We review the treatment flow and your current healthcare process.
- 02
Agreement and data management
Personal data processor agreement and information security in place.
- 03
Team training
The treating staff are trained in the method and the web interface.
- 04
First patients
You start with a small number of families and then scale up.
Would you like to see how Evira would work at your clinic?
We'll go through the treatment flow, the requirements of the care programme, and what an implementation entails for your team.